Advertisement

Diabetes in the Young

  • Anil Bhansali
  • Anuradha Aggarwal
  • Girish Parthan
  • Yashpal Gogate
Chapter

Abstract

What is diabetes in the young?

Keywords

KATP Channel Intensive Insulin Therapy Glucagon Secretion Acanthosis Nigricans Neonatal Diabetes 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Readings

  1. 1.
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31:S55–60.CrossRefGoogle Scholar
  2. 2.
    American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38:S1–90.Google Scholar
  3. 3.
    DeGroot L, Jameson J. Endocrinology. Philadelphia: Saunders/Elsevier; 2010.Google Scholar
  4. 4.
    Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001;345:971–80.CrossRefPubMedGoogle Scholar
  5. 5.
    Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes. 2007;56:1930–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Melmed S, Williams R. Williams textbook of endocrinology. Philadelphia: Elsevier/Saunders; 2011.Google Scholar
  7. 7.
    Stenstrom G, Gottsater A, Bakhtadze E, et al. Latent autoimmune diabetes in adults: definition, prevalence β-cell function, and treatment. Diabetes. 2005;54:S69–72.CrossRefGoogle Scholar
  8. 8.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977.CrossRefGoogle Scholar
  9. 9.
    The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Umpierrez GE. Ketosis-prone type 2 diabetes time to revise the classification of diabetes. Diabetes Care. 2006;29:2755–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Unnikrishnan R, Mohan V. Fibrocalculous pancreatic diabetes (FCPD). Acta Diabetol. 2015;52:1–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Anil Bhansali
    • 1
  • Anuradha Aggarwal
    • 2
  • Girish Parthan
    • 3
  • Yashpal Gogate
    • 4
  1. 1.Department of EndocrinologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia
  2. 2.Paras HospitalPatnaIndia
  3. 3.Renal MedicityCochinIndia
  4. 4.Harmony Health HubNasikIndia

Personalised recommendations